Cystic Fibrosis Foundation vs Epicrispr Biotechnologies
Cystic Fibrosis Foundation vs Epicrispr Biotechnologies, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cystic Fibrosis Foundation is on 59/100 and Epicrispr Biotechnologies on 62/100.
Where each one leads
Cystic Fibrosis Foundation
- domain rating: 80/100 against 40/100
- headcount: 1,183 against 51
Epicrispr Biotechnologies
- agent readiness: 39/100 against 25/100
- funding raised: $90.0M against $9.3M
At a glance
| Measure | Cystic Fibrosis Foundation | Epicrispr Biotechnologies |
|---|---|---|
| What it is | A leading organization dedicated to curing and treating cystic fibrosis. | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). |
| Category | Biotechnology, Healthcare, Non-profit | Biotechnology, Therapeutics, Rare Diseases, Epigenetics |
| Sells toBusiness model | B2G | B2B |
| Offering | Services | Platform |
| Founded | 1955 | 2020 |
| Headquarters | Bethesda, USA | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cystic Fibrosis Foundation | Epicrispr Biotechnologies |
|---|---|---|
| Employees | 1,183 | 51 |
| Total funding | $9.3M | $90.0M |
| Latest round | Series A | Series C |
| LinkedIn followers | Not published | 7,025 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cystic Fibrosis Foundation | Epicrispr Biotechnologies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 62/100 |
| Traction | 55/100 | 57/100 |
| Team | 30/100 | 40/100 |
| Search visibility | 2/100 | 20/100 |
| Quality | 78/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (25/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 80/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cystic Fibrosis Foundation | Epicrispr Biotechnologies |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Analytics 4 |
Cystic Fibrosis Foundation vs Epicrispr Biotechnologies: common questions
Which is better, Cystic Fibrosis Foundation or Epicrispr Biotechnologies?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Cystic Fibrosis Foundation and Epicrispr Biotechnologies compare on the numbers?
Cystic Fibrosis Foundation leads on domain rating (80/100 against 40/100), headcount (1,183 against 51). Epicrispr Biotechnologies leads on agent readiness (39/100 against 25/100), funding raised ($90.0M against $9.3M).
Read the full Cystic Fibrosis Foundation review and pricing or the Epicrispr Biotechnologies review and pricing. You can also browse other Cystic Fibrosis Foundation alternatives we track.